Study shows improvement in disability-free life for older Americans

A sizeable improvement was found in the prevalence of American adults aged 65 and older without disabilities — including memory, hearing, visual, and functional disabilities or limitations in activities of daily living — according to a new nationally representative study published online in the Archives of Gerontology and Geriatrics Plus found.

(Ceftibuten + xeruborbactam) by Qpex Biopharma for Pyelonephritis: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

January 5, 2024

Precision medicine enhances prostate cancer treatment with genetic profiling

Men with metastatic castration-resistant prostate cancer should be treated primarily with second-generation hormone drugs, which offer better treatment response and longer life expectancy than chemotherapy.

August 20, 2024

Mohs Surgery Best for Early-Stage Merkel Cell Carcinoma?

Mohs micrographic surgery may offer a survival advantage over wide local excision for select patients with early-stage Merkel cell carcinoma (MCC), a retrospective cohort study

August 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.